P eople who inject drugs are the fastest-growing group at risk for hepatitis C. And yet, after receiving a diagnosis, many struggle to find sympathetic care and support, from both healthcare providers ...

W hen hepatitis C was first discovered in 1989, the virus was spread largely through blood transfusions, before the blood supply was regularly screened for the virus. Now, though, hepatitis C is ...

CHICAGO (Reuters) - Two standard treatments for hepatitis C work equally well at knocking down the virus for most patients, U.S. researchers reported on Wednesday. The findings, from a 3,000-patient ...

The direct-acting antiviral glecaprevir/pibrentasvir (Mavyret) was highly effective and well tolerated in adults with acute ...

Given that HCV is a bloodborne virus, any circumstance that promotes continued drug injection—including failure to prevent or diagnose and adequately treat substance use disorders—can result in ...

(Reuters) - A trio of oral medicines from Abbott Laboratories Inc to treat hepatitis C produced unprecedented cure rates in patients who had failed to benefit from standard treatment, as well as very ...

Hepatitis C is an infection of the liver caused by the hepatitis C virus (HCV). Experts estimate that about 2.4 million people in the United States are living with hepatitis C—but that figure could be ...

In 2005, Nick Voyles was diagnosed with hepatitis C after being released from five years of incarceration. A nurse told him he had only six months to live. He was prescribed a drug cocktail, a ...

Figure 1. The direct-acting antiviral targets in the hepatitis C virus replication cycle. NS3/4A protease inhibitors target the NS3/4A protease enzyme which is needed for the virus to develop the ...

Pharmasset, Inc. has received fast-track designation from the U.S. Food and Drug Administration for R7128 for the treatment of chronic hepatitis C virus infection.Pharmasset, Inc. (Nasdaq: VRUS) has ...

There's a new drug regimen being touted as a potential cure for a dangerous liver virus that causes hepatitis C. But it costs $84,000 -- or $1,000 a pill. And that price tag is prompting outrage from ...

Fifty-year-old Tapestry says it provides syringe access, overdose prevention, HIV and hepatitis C testing, and health care across Western Massachusetts.